Handelen Quanterix - QTRX CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Spread | 0.07 | ||||||||
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.024874% | ||||||||
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | 0.002651% | ||||||||
Tijd van overnight-tarief | 21:00 (UTC) | ||||||||
Min. verhandelde hoeveelheid | 1 | ||||||||
Valuta | USD | ||||||||
Marge | 20% | ||||||||
Effectenbeurs | United States of America | ||||||||
Handelscommissie | 0% |
*Information provided by Capital.com
Prev. Close* | 10.82 |
Open* | 11.03 |
1-Jaarlijkse Verandering* | -61.45% |
Dagelijks bereik* | 11.03 - 11.43 |
52 wekelijks bereik | 6.31-31.33 |
Weekgemiddelde volume (10 dagen) | 283.52K |
Gemiddeld volume (3 maanden) | 6.59M |
Marktkapitalisatie | 404.15M |
P/E Ratio | -100.00K |
Uitstaande Aandelen | 37.25M |
Omzet | 105.52M |
EPS | -2.61 |
Dividend (opbrengst %) | N/A |
Beta | 1.34 |
Volgende inkomsten datum | May 8, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
---|---|---|---|---|---|---|
Mar 31, 2023 | 11.22 | 0.39 | 3.60% | 10.83 | 11.43 | 10.83 |
Mar 30, 2023 | 10.82 | -0.12 | -1.10% | 10.94 | 11.04 | 10.63 |
Mar 29, 2023 | 10.83 | 0.70 | 6.91% | 10.13 | 10.89 | 10.13 |
Mar 28, 2023 | 10.06 | -0.37 | -3.55% | 10.43 | 10.47 | 9.99 |
Mar 27, 2023 | 10.55 | -0.03 | -0.28% | 10.58 | 10.82 | 10.51 |
Mar 24, 2023 | 10.55 | 0.07 | 0.67% | 10.48 | 10.70 | 10.22 |
Mar 23, 2023 | 10.68 | -0.09 | -0.84% | 10.77 | 11.42 | 10.62 |
Mar 22, 2023 | 10.75 | -1.03 | -8.74% | 11.78 | 11.78 | 10.74 |
Mar 21, 2023 | 11.76 | 0.54 | 4.81% | 11.22 | 11.89 | 11.17 |
Mar 20, 2023 | 11.20 | -0.65 | -5.49% | 11.85 | 11.85 | 11.08 |
Mar 17, 2023 | 11.87 | 0.14 | 1.19% | 11.73 | 12.49 | 11.71 |
Mar 16, 2023 | 12.04 | 0.66 | 5.80% | 11.38 | 12.32 | 11.38 |
Mar 15, 2023 | 11.86 | 0.19 | 1.63% | 11.67 | 12.04 | 11.56 |
Mar 14, 2023 | 12.09 | -0.50 | -3.97% | 12.59 | 12.59 | 11.82 |
Mar 13, 2023 | 12.12 | 0.43 | 3.68% | 11.69 | 12.12 | 11.34 |
Mar 10, 2023 | 11.93 | -0.30 | -2.45% | 12.23 | 12.39 | 11.67 |
Mar 9, 2023 | 12.49 | -0.03 | -0.24% | 12.52 | 13.30 | 12.28 |
Mar 8, 2023 | 12.68 | 0.14 | 1.12% | 12.54 | 12.82 | 12.33 |
Mar 7, 2023 | 12.79 | -0.86 | -6.30% | 13.65 | 14.12 | 12.55 |
Mar 6, 2023 | 13.54 | 2.17 | 19.09% | 11.37 | 13.71 | 11.37 |
Quanterix Events
Tijd (UTC) (UTC) | Land | Evenement |
---|---|---|
No events scheduled |
- Jaarlijks
- Per kwartaal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Totale inkomsten | 105.522 | 110.556 | 86.377 | 56.734 | 37.632 |
Inkomsten | 105.522 | 110.556 | 86.377 | 56.734 | 37.632 |
Kosten van opbrengsten, totaal | 58.716 | 48.828 | 38.195 | 29.898 | 19.684 |
Brutowinst | 46.806 | 61.728 | 48.182 | 26.836 | 17.948 |
Totale bedrijfskosten | 207.226 | 169.142 | 117.961 | 98.334 | 69.182 |
Verkoop/Algemeen/Admin. Uitgaven, Totaal | 93.273 | 92.336 | 59.592 | 52.246 | 33.693 |
Onderzoek & Ontwikkeling | 25.89 | 27.978 | 20.174 | 16.19 | 15.805 |
Bedrijfsresultaat | -101.704 | -58.586 | -31.584 | -41.6 | -31.55 |
Renteopbrengsten (-uitgaven), netto Niet-operationeel | 5.131 | -0.403 | -0.273 | 0.627 | 0.046 |
Overige, Netto | -0.062 | 1.265 | -0.049 | -0.01 | -0.007 |
Netto inkomen voor belastingen | -96.635 | -57.724 | -31.906 | -40.983 | -31.511 |
Netto inkomen na belastingen | -96.7 | -57.688 | -31.53 | -40.796 | -31.536 |
Netto inkomen voor extra. Posten | -96.7 | -57.688 | -31.53 | -40.796 | -31.536 |
Netto inkomen | -96.7 | -57.688 | -31.53 | -40.796 | -31.536 |
Total Adjustments to Net Income | 0 | 0 | |||
Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | -96.7 | -57.688 | -31.53 | -40.796 | -31.536 |
Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | -96.7 | -57.688 | -31.53 | -40.796 | -31.536 |
Verwateringsaanpassing | |||||
Verwaterd Netto Inkomen | -96.7 | -57.688 | -31.53 | -40.796 | -31.536 |
Verwaterd Gewogen Gemiddelde Aandelen | 36.991 | 35.9975 | 29.5891 | 25.0907 | 21.9943 |
Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | -2.61415 | -1.60256 | -1.06559 | -1.62594 | -1.43382 |
Dividends per Share - Common Stock Primary Issue | |||||
Verwaterde Genormaliseerde Winst per Aandeel | -2.09847 | -1.60256 | -1.06559 | -1.62594 | -1.43382 |
Ongebruikelijke uitgaven (inkomsten) | 29.347 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Totale inkomsten | 25.824 | 26.646 | 23.5 | 29.552 | 30.287 |
Inkomsten | 25.824 | 26.646 | 23.5 | 29.552 | 30.287 |
Kosten van opbrengsten, totaal | 13.232 | 15.702 | 14.789 | 14.993 | 14.026 |
Brutowinst | 12.592 | 10.944 | 8.711 | 14.559 | 16.261 |
Totale bedrijfskosten | 47.779 | 63.249 | 48.459 | 47.739 | 50.183 |
Verkoop/Algemeen/Admin. Uitgaven, Totaal | 19.941 | 20.575 | 27.045 | 25.712 | 28.423 |
Onderzoek & Ontwikkeling | 5.6 | 6.631 | 6.625 | 7.034 | 7.734 |
Bedrijfsresultaat | -21.955 | -36.603 | -24.959 | -18.187 | -19.896 |
Renteopbrengsten (-uitgaven), netto Niet-operationeel | 2.815 | 1.712 | 0.552 | 0.052 | 0.015 |
Overige, Netto | 0.614 | -0.101 | -0.358 | -0.217 | -0.213 |
Netto inkomen voor belastingen | -18.526 | -34.992 | -24.765 | -18.352 | -20.094 |
Netto inkomen na belastingen | -18.581 | -35.064 | -24.902 | -18.153 | -20.026 |
Netto inkomen voor extra. Posten | -18.581 | -35.064 | -24.902 | -18.153 | -20.026 |
Netto inkomen | -18.581 | -35.064 | -24.902 | -18.153 | -20.026 |
Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | -18.581 | -35.064 | -24.902 | -18.153 | -20.026 |
Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | -18.581 | -35.064 | -24.902 | -18.153 | -20.026 |
Verwaterd Netto Inkomen | -18.581 | -35.064 | -24.902 | -18.153 | -20.026 |
Verwaterd Gewogen Gemiddelde Aandelen | 37.1842 | 37.0046 | 36.9225 | 36.8509 | 36.6665 |
Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | -0.4997 | -0.94756 | -0.67444 | -0.49261 | -0.54617 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Verwaterde Genormaliseerde Winst per Aandeel | -0.34227 | -0.59026 | -0.67444 | -0.49261 | -0.54617 |
Ongebruikelijke uitgaven (inkomsten) | 9.006 | 20.341 |
- Jaarlijks
- Per kwartaal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Totaal vlottende activa | 448.955 | 219.605 | 132.661 | 59.496 | 89.252 |
Geldmiddelen en kortetermijnbeleggingen | 396.465 | 181.584 | 109.155 | 44.429 | 79.682 |
Cash | 6.406 | 1.821 | 1.5 | ||
Korte Termijn Investeringen | 102.749 | 42.608 | 78.182 | ||
Totale Vorderingen, Netto | 23.786 | 17.184 | 10.906 | 6.792 | 5.599 |
Accounts Receivable - Trade, Net | 23.786 | 17.184 | 10.906 | 6.792 | 5.599 |
Total Inventory | 22.19 | 14.856 | 10.463 | 5.945 | 3.571 |
Prepaid Expenses | 6.514 | 5.981 | 2.137 | 2.33 | 0.4 |
Other Current Assets, Total | |||||
Total Assets | 501.527 | 271.045 | 169.951 | 67.611 | 91.779 |
Property/Plant/Equipment, Total - Net | 29.451 | 25.907 | 12.047 | 2.923 | 1.874 |
Property/Plant/Equipment, Total - Gross | 37.156 | 32.343 | 16.386 | 5.946 | 4.297 |
Accumulated Depreciation, Total | -7.705 | -6.436 | -4.339 | -3.023 | -2.423 |
Other Long Term Assets, Total | 2.955 | 1.357 | 1.583 | 1.536 | 0.653 |
Total Current Liabilities | 36.977 | 39.803 | 19.833 | 18.125 | 19.714 |
Accounts Payable | 9.209 | 6.799 | 5.777 | 5.11 | 3.552 |
Accrued Expenses | 21.166 | 16.856 | 9.068 | 7.578 | 6.184 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 7.673 | 0.075 | 0 | 5.036 |
Other Current Liabilities, Total | 6.602 | 8.475 | 4.913 | 5.437 | 4.942 |
Total Liabilities | 60.575 | 64.92 | 41.293 | 26.546 | 25.913 |
Total Long Term Debt | 0 | 0 | 7.587 | 7.623 | 4.346 |
Long Term Debt | 0 | 7.587 | 7.623 | 4.346 | |
Other Liabilities, Total | 21.563 | 22.468 | 13.873 | 0.798 | 1.853 |
Total Equity | 440.952 | 206.125 | 128.658 | 41.065 | 65.866 |
Redeemable Preferred Stock | 0 | ||||
Common Stock | 0.037 | 0.032 | 0.028 | 0.022 | 0.022 |
Additional Paid-In Capital | 745.936 | 451.433 | 345.027 | 216.931 | 210.196 |
Retained Earnings (Accumulated Deficit) | -305.462 | -247.774 | -216.244 | -175.888 | -144.352 |
Total Liabilities & Shareholders’ Equity | 501.527 | 271.045 | 169.951 | 67.611 | 91.779 |
Total Common Shares Outstanding | 36.768 | 31.7965 | 28.1122 | 22.369 | 21.707 |
Goodwill, Net | 9.632 | 10.46 | 9.353 | 1.308 | |
Intangibles, Net | 10.534 | 13.716 | 14.307 | 2.348 | |
Other Equity, Total | 0.441 | 2.434 | -0.153 | ||
Geldmiddelen & Equivalenten | 396.465 | 181.584 | |||
Deferred Income Tax | 2.035 | 2.649 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Totaal vlottende activa | 433.706 | 448.955 | 459.429 | 476.44 | 482.443 |
Geldmiddelen en kortetermijnbeleggingen | 374.317 | 396.465 | 410.747 | 430.78 | 442.672 |
Geldmiddelen & Equivalenten | 374.317 | 396.465 | 410.747 | 430.78 | 442.672 |
Totale Vorderingen, Netto | 22.616 | 23.786 | 18.434 | 15.43 | 14.936 |
Accounts Receivable - Trade, Net | 22.616 | 23.786 | 18.434 | 15.43 | 14.936 |
Total Inventory | 22.669 | 22.19 | 22.794 | 21.225 | 17.044 |
Prepaid Expenses | 14.104 | 6.514 | 7.454 | 9.005 | 7.791 |
Total Assets | 504.657 | 501.527 | 510.84 | 528.044 | 532.666 |
Property/Plant/Equipment, Total - Net | 48.981 | 29.451 | 28.092 | 27.532 | 26.053 |
Goodwill, Net | 9.323 | 9.632 | 9.903 | 10.121 | 9.933 |
Intangibles, Net | 9.692 | 10.534 | 11.374 | 12.174 | 12.464 |
Other Long Term Assets, Total | 2.955 | 2.955 | 2.042 | 1.777 | 1.773 |
Total Current Liabilities | 31.773 | 36.977 | 31.19 | 37.675 | 36.491 |
Accounts Payable | 4.262 | 9.209 | 5.824 | 6.862 | 6.503 |
Accrued Expenses | 18.049 | 21.166 | 16.425 | 15.324 | 13.889 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 1.993 | 7.716 | 7.694 | |
Other Current Liabilities, Total | 9.462 | 6.602 | 6.948 | 7.773 | 8.405 |
Total Liabilities | 78.249 | 60.575 | 55.326 | 62.034 | 61.197 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Long Term Debt | 0 | ||||
Deferred Income Tax | 1.691 | 2.035 | 2.362 | 2.409 | 2.378 |
Other Liabilities, Total | 44.785 | 21.563 | 21.774 | 21.95 | 22.328 |
Total Equity | 426.408 | 440.952 | 455.514 | 466.01 | 471.469 |
Common Stock | 0.037 | 0.037 | 0.037 | 0.037 | 0.036 |
Additional Paid-In Capital | 750.742 | 745.936 | 739.862 | 734.17 | 728.128 |
Retained Earnings (Accumulated Deficit) | -323.615 | -305.462 | -285.436 | -269.775 | -257.878 |
Other Equity, Total | -0.756 | 0.441 | 1.051 | 1.578 | 1.183 |
Total Liabilities & Shareholders’ Equity | 504.657 | 501.527 | 510.84 | 528.044 | 532.666 |
Total Common Shares Outstanding | 36.8992 | 36.768 | 36.5741 | 36.4544 | 36.2949 |
- Jaarlijks
- Per kwartaal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netto-inkomen/Beginsaldo | -57.688 | -31.53 | -40.796 | -31.536 | -27.019 |
Geldmiddelen uit Operationele Activiteiten | -47.907 | -23.365 | -26.187 | -28.721 | -22.106 |
Geldmiddelen uit Operationele Activiteiten | 4.851 | 4.312 | 3.009 | 1.352 | 0.482 |
Niet-Geldelijke Posten | 17.116 | 11.323 | 7.228 | 5.04 | 2.496 |
Contant Betaalde Rente | 0.389 | 0.625 | 0.656 | 0.66 | 0.743 |
Veranderingen in het Operationeel Kapitaal | -12.186 | -7.47 | 4.372 | -3.577 | 1.935 |
Geldmiddelen uit Investeringsactiviteiten | -6.338 | -0.626 | -25.376 | -5.454 | -1.132 |
Kapitaaluitgaven | -13.616 | -3.93 | -10.847 | -1.518 | -1.132 |
Overige Cash Flow investeringsposten, Totaal | 7.278 | 3.304 | -14.529 | -3.936 | 0 |
Geldmiddelen uit Financieringsactiviteiten | 270.795 | 96.236 | 116.197 | -0.078 | 73.249 |
Uitgifte (Aflossing) van aandelen, netto | 278.533 | 96.311 | 116.247 | 1.851 | 74.229 |
Uitgifte (Aflossing) van Schulden, Netto | -7.738 | -0.075 | -0.05 | -1.929 | -0.98 |
Nettowijziging in Geldmiddelen | 216.458 | 72.403 | 64.752 | -34.253 | 50.011 |
Wisselkoerseffecten | -0.092 | 0.158 | 0.118 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -18.153 | -57.688 | -37.662 | -22.001 | -10.104 |
Cash From Operating Activities | -21.695 | -47.907 | -37.615 | -23.838 | -14.089 |
Cash From Operating Activities | 1.358 | 4.851 | 3.566 | 2.344 | 1.151 |
Non-Cash Items | 4.004 | 17.116 | 12.034 | 7.62 | 3.72 |
Cash Interest Paid | 0.389 | 0.389 | 0.309 | 0.154 | |
Changes in Working Capital | -8.904 | -12.186 | -15.553 | -11.801 | -8.856 |
Cash From Investing Activities | -0.874 | -6.338 | -4.144 | -2.129 | 2.435 |
Capital Expenditures | -1.394 | -13.616 | -11.163 | -7.339 | -0.079 |
Other Investing Cash Flow Items, Total | 0.52 | 7.278 | 7.019 | 5.21 | 2.514 |
Cash From Financing Activities | 0.979 | 270.795 | 271.646 | 275.706 | 273.313 |
Issuance (Retirement) of Stock, Net | 0.979 | 278.533 | 277.39 | 275.706 | 273.313 |
Issuance (Retirement) of Debt, Net | -7.738 | -5.744 | 0 | 0 | |
Foreign Exchange Effects | -0.558 | -0.092 | -0.066 | -0.143 | -0.171 |
Net Change in Cash | -22.148 | 216.458 | 229.821 | 249.596 | 261.488 |
Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
---|---|---|---|---|---|---|
Camber Capital Management LP | Hedge Fund | 9.195 | 3425000 | 425000 | 2022-12-31 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.3229 | 2355178 | 69024 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.9234 | 1833912 | 22903 | 2022-12-31 | LOW |
Millennium Management LLC | Hedge Fund | 4.4167 | 1645165 | -163361 | 2022-12-31 | HIGH |
Frontier Capital Management Company, LLC | Investment Advisor | 4.157 | 1548415 | -386204 | 2022-12-31 | LOW |
Walt (David R) | Individual Investor | 3.8571 | 1436727 | 8083 | 2023-01-03 | LOW |
Granahan Investment Management, Inc. | Investment Advisor | 3.3868 | 1261552 | -11387 | 2022-12-31 | LOW |
Point72 Asset Management, L.P. | Hedge Fund | 2.9285 | 1090826 | 734306 | 2022-12-31 | HIGH |
Platinum Asset Management | Investment Advisor/Hedge Fund | 2.701 | 1006097 | -149721 | 2022-12-31 | LOW |
DWS Investments UK Limited | Investment Advisor | 2.6647 | 992562 | 977677 | 2022-12-31 | MED |
Ashford Capital Management, Inc. | Investment Advisor/Hedge Fund | 2.6087 | 971698 | 69405 | 2022-12-31 | LOW |
Gilder Gagnon Howe & Co. LLC | Hedge Fund | 2.5328 | 943421 | -508171 | 2022-12-31 | LOW |
Hrusovsky (Edward Kevin) | Individual Investor | 2.3495 | 875171 | -960 | 2022-07-05 | LOW |
Portolan Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 2.3148 | 862225 | 103372 | 2022-12-31 | HIGH |
Columbia Threadneedle Investments (UK) | Investment Advisor/Hedge Fund | 2.225 | 828765 | 4753 | 2022-12-31 | LOW |
D. E. Shaw & Co., L.P. | Hedge Fund | 2.0993 | 781974 | 222178 | 2022-12-31 | MED |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 1.8201 | 677948 | 13906 | 2022-12-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 1.8032 | 671679 | -138437 | 2022-12-31 | HIGH |
Tikvah Management LLC | Hedge Fund | 1.7386 | 647619 | 0 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.7186 | 640159 | 21726 | 2022-12-31 | LOW |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com Group500K+
Handelaren
92K+
Actieve klanten per maand
$53M+
Maandelijks beleggingsvolume
$30M+
Opgenomen per maand
Handelscalculator
Bereken uw virtuele winst- en verliesrekening indien u een CFD-positie had geopend op een bepaalde datum (kies een datum) en gesloten op een andere datum (kies een datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Quanterix Company profile
Over Quanterix
Quanterix Corporation is een biowetenschapsbedrijf. Het bedrijf houdt zich bezig met de ontwikkeling van ultragevoelige digitale immunoassay-platforms die de precisiegezondheid bevorderen voor biowetenschappelijk onderzoek en diagnostiek. Haar platforms zijn gebaseerd op haar digitale Simoa-detectietechnologie. Haar Simoa bead-based en planar array platforms stellen klanten in staat om betrouwbaar proteïne biomarkers te detecteren bij extreem lage concentraties in bloed, serum en andere vloeistoffen. De producten omvatten HD-X Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, en 2470 Arrayer. Het levert ook NF-Light antilichamen en ELISA kits, die oplossingen bieden voor de detectie van neurofilament light (Nf-L) voor de ontwikkeling van therapeutica en diagnostica voor neurodegeneratieve aandoeningen. De portefeuille van beschikbare kits bestrijkt meerdere therapeutische gebieden, waaronder cardiologie, infectieziekten, ontsteking, neurologie en oncologie. Het bedrijf levert diensten via zijn Simoa Accelerator Laboratory.
Industry: | Advanced Medical Equipment & Technology (NEC) |
900 Middlesex Turnpike
BILLERICA
MASSACHUSETTS 01821
US
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 500.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen